Previous research has shown that TPH2 protein and TPH2 mRNA levels are altered in the brains of AD patients, with higher levels found in the dorsal and median raphe nuclei of AD patients than of healthy controls [38]. This evidence concerns the gene TPH2 and Alzheimer disease.